Clinical Trials in Nashville

Showing 1981-2000 of 9,711 trials

A Study of Nemtabrutinib (MK-1026) in Participants With Relapsed or Refractory Hematologic Malignancies (ARQ 531-101/MK-1026-001)

NCT03162536

This study aims to evaluate the safety, tolerability, pharmacodynamic, and pharmacokinetic (PK) of nemtabrutinib (formerly ARQ 531) tablets in selected participants with relapsed or refractory hematologic malignancies. No formal hypothesis testing will be performed for this study.

Lymphoma, B-CellSmall Lymphocytic LymphomaChronic Lymphocytic Leukemia+6 more

ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)190 participantsStarted Jun 2017

Scottsdale, Arizona, United States • Los Angeles, California, United States • Denver, Colorado, United States +7 more locations

Active Not RecruitingPhase 3< 1 mile

A Study Evaluating the Long-term Safety and Efficacy of VX-121 Combination Therapy

NCT05444257

The purpose of this study is to evaluate the long-term safety, tolerability, and efficacy of VX-121/tezacaftor/deutivacaftor (VX-121/TEZ/D-IVA) in participants with cystic fibrosis.

Cystic Fibrosis

Vertex Pharmaceuticals Incorporated822 participantsStarted Nov 2022

Birmingham, Alabama, United States • Tucson, Arizona, United States • Little Rock, Arkansas, United States +192 more locations

A Study of Nemtabrutinib (MK-1026) in Participants With Relapsed or Refractory Hematologic Malignancies (ARQ 531-101/MK-1026-001)

A Study Evaluating the Long-term Safety and Efficacy of VX-121 Combination Therapy

Find Trials by Condition in Nashville

A Study of ELI-002 in Subjects With KRAS Mutated Pancreatic Ductal Adenocarcinoma (PDAC) and Other Solid Tumors

Sympathetic Mechanisms in the Cardiovascular and Metabolic Alterations of Obesity

Cholinergic Mechanisms of Attention in Aging

A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Eosinophilic Asthma

Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer

CREST-2 Long-term Observational Extension Study

A Study of Danicopan in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration

Regorafenib and Durvalumab for the Treatment of High-Risk Liver Cancer

Gla-300 and IDeg-100 in Insulin-Naïve People With Type 2 Diabetes Mellitus and Renal Impairment

International Rare Brain Tumor Registry

A Study to Test Whether BI 706321 Combined With Ustekinumab Helps People With Crohn's Disease

QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast Cancer

Maximal Use Study of Tapinarof Cream, 1% in Pediatric Subjects With Extensive Atopic Dermatitis

A Phase I/II Study of Hypofractionated Proton Therapy for Stage II-III Non-Small Cell Lung Cancer

Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer

The PLATFORM Study: Prospective LongitudinAl Trial of FFRct: Outcome and Resource IMpacts)

Safety, Usability, and Effectiveness of a Gait Exoskeleton for Children and Adolescents With Neurodevelopmental Disorders.

Skin Reactions Related to Thoracic Implantable Chamber Dressings